Xie, Wei
Shi, Lei
Quan, Hu
Xiao, Hua
Chen, Jie
Liu, Jia
de Dieu Habimana, Jean
Huang, Rongqi
Luo, Jia
Chen, Pan
Li, Zhiyuan
Funding for this research was provided by:
the National Natural Science Foundation of China (82173201, 81827803, 82173201, 81827803, 82173201, 81827803)
the Natural Science Foundation of Hunan Province (No.2022JJ70020, No.2022JJ70020, No.2022JJ70020)
Hunan Cancer Hospital Climb Plan (No.2020NSFC-A001, ZX2021003, No.2020NSFC-A001, ZX2021003, No.2020NSFC-A001, ZX2021003)
Article History
Accepted: 4 April 2023
First Online: 26 April 2023
Declarations
:
: A cohort of 30 HCC tissues and their normal counterparts were collected from HCC patients from Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University. Written consents from all patients were obtained. This study was approved by Ethics Committee of Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University.Animal study was approved by the Ethics Committee of Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University.
: The informed consent obtained from study participants.
: There is no conflict of interest.